Clinical Trial - No-Added-Sugar Ice Cream

Postprandial Glycaemic Changes When Patients With Type 2 Diabetes Consume the New KDD Products

KDD commissioned DDI to implement a scientific breakthrough regarding a Kuwaiti food product: a double-blinded randomized cross-over clinical trial with the highest level of evidence. The trial compared the post-prandial glucose and insulin response of no-added-sugar ice cream to conventional ice cream with added sugar. The no-added-sugar ice cream showed significantly lowered blood glucose and insulin responses in patients with diabetes.

Study Overview

Brief Summary

KDD is developing a new line of no-added-sugar products in line with its metabolic reengineering initiative and its metabolic matrix. The recipes fundamentally do not alter total saturated fat or protein levels and mainly offer the benefit of no added sugar and a significant reduction in net carbohydrates as well glycaemic index.

Detailed Description
The consumption of highly ultra-processed foods has been identified as having detrimental effects on human metabolic health, leading to various adverse health outcomes. The Metabolic Matrix represents a highly quantified, science-based tool for reengineering products with the aim of promoting positive metabolic outcomes. This approach may also contribute to creating shared value by solving important social problems such as obesity and type 2 diabetes by scalable products that are profitable.

KDD is committed to addressing the pandemic of metabolic diseases in Kuwait and would like to develop products that benefit the collective metabolic health of the Kuwait population. KDD is working with partners to assist in its ground-breaking work and to support its efforts with a strong evidence-base rooted in leading-edge science in metabolic health and nutrition. We hypothesise that no-added sugar-flavored ice cream have a substantially different postprandial glycaemic response compared to conventional products in patients with type 2 diabetes.

ClinicalTrials.gov ID NCT06135935

Sponsor Dasman Diabetes Institute

Information provided by Dr. Ebaa Al Ozairi, Dasman Diabetes Institute (Responsible Party)

Source: https://www.clinicaltrials.gov/study/NCT06135935

No Sugar Added Event – Featuring the NAS Ice Cream Clinical Trial

Wednesday, 12 June, 2024, 10:00 a.m – 02:00 p.m

Research & Development through Partnership

The event disseminated the results of a collaborative project initiated by KDD, funded by KFAS and clinically researched by DDI, aimed at developing a suite of no-added-sugar products created on the science-based Metabolic Matrix, a framework for reengineering food and beverages for optimal health impacts supported by clinical evidence of efficacy. The focus was on re-engineering KDD’s popular chocolate ice cream, documenting the deployment of a metabolic matrix to create scalable and replicable solutions. Sugar alternatives were identified through research, laboratory, and consumer testing by KDD. Partnering with Dasman Diabetes Institute (DDI) allowed a clinical trial to be conducted on people with diabetes by a Kuwaiti team of researchers led by Dr. Ebaa Al Ozairi. This produced high-level evidence scientifically quantifying the metabolic benefits of eliminating added sugar in ice cream. The results of this project were presented for the first time during this event. The work exemplifies the effectiveness of partnerships in research and development between the public and private sectors in Kuwait, and the new formulation exemplifies an opportunity for shared care value for end consumers.

Articles about this event published in Kuwait:

Kuwait City, June 12: A groundbreaking collaboration between KDD, the Kuwait Foundation for the Advancement of Science (KFAS), and the Dasman Diabetes Institute (DDI) has resulted in the development of a new no-added-sugar chocolate ice cream product aimed at improving metabolic health and nutrition.

Several well-known dignitaries, senior officials from various sectors, and the general public were invited to a symposium hosted by KFAS at DDI on June 12, 2024, from 10 am to 2 pm, where the science and collaboration behind this innovative product was unveiled.

With over 20 percent of Kuwaitis affected by diabetes mellitus and a significant portion suffering from metabolic diseases and chronic health conditions, the need for healthier food options is paramount.

The initiative by KDD to create products catering to metabolic health, including improved insulin response, represents a significant leap in its innovation strategy of reducing or eliminating added sugars.

The research conducted by KDD in collaboration with DDI involved a double-blind randomized cross-over clinical trial, comparing the metabolic effects of the no-added-sugar ice cream to conventional varieties with added sugar.

The results demonstrated significantly lower blood glucose and insulin responses in patients with diabetes, highlighting the potential health benefits of the new product.

This ice cream innovation is the first in a series of ‘Good for Me’ products developed based on the Metabolic Matrix, a science-based framework focussed on the 3 pillars of protect the liver, feed the gut and support the brain. The Metabolic Matrix has gained global recognition and was featured in a peer-reviewed methods paper.

By the end of June 2024, KDD’s no-added-sugar ice cream will be available in chocolate, vanilla, and strawberry flavors at major co-operatives, hypermarkets, and KDD outlets, offering consumers a delicious and nutritious treat aligned with their health goals.

Source: Arab Times Kuwait 12-JUNE-2024